BICO Group (OM:BICO) Stock Rally Meets Lingering Cash Flow Doubts

BICO Group stock has climbed 41.1% over the past month to close at SEK19.28 on Thursday, which indicates that traders are already repositioning around the story. The headline today is not a sudden return to profit; it is a sharp easing of the earnings squeeze. Quarterly revenue landed at SEK336.1m while the company still reported a loss, with basic earnings per share at SEK0.53 in the red.

The key message for longer term holders is that profit pressure remains heavy, even as the latest quarter points to a less severe margin hit than earlier in the year.

Is BICO Group a genuine bargain at a 0.9x P/S and a share price far below the fair value estimate, or is the discount a clear warning signal? Compare that gap against the full valuation analysis for BICO Group.

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs Q2 2025): SEK336.1m vs. SEK324.2m (higher year on year)
• Net Income or Loss (Q2 2026 vs Q2 2025): loss of SEK37.2m vs. loss of SEK182.8m (loss narrowed)
• Basic EPS (Q2 2026 vs Q2 2025): loss of SEK0.53 per share vs. loss of SEK2.59 per share (loss per share narrowed)
• Gross Margin (Q2 2026 vs Q2 2025): 59% vs. 44% (margin improved)

Prefer clear visuals instead of another wall of numbers on BICO Group? Get a full picture of the company, including how the balance sheet stacks up, in our interactive company report for BICO Group.

BICO Group’s Bull Case Hinges On Automation Proof Points

Bullish investors argue that BICO Group can turn its lab automation and software backbone into steady, higher margin growth as framework agreements scale. Q2 gives partial support to that view, but with clear boundaries.

On the positive side, organic revenue growth of 7% in local currency, a 59% gross margin and lower operating expenses all line up with the idea of better mix and improved project execution. Stronger benchtop instruments and consumables, plus the 10 year Scienion license and supply deal worth about €50m, show customers are willing to commit to BICO workflows for the long haul.

At the same time, project based lab automation remains pressured, North America declined and operating cash flow was still negative. That signals the “commercialization and profitable growth” phase is only partly validated so far, not fully proven.

Compare those healthier margins and longer term contracts with what the street is pricing in right now. See the consensus price target analysis for BICO Group to check how current targets stack up against the BICO Group turnaround story.

BICO Bear Case: Cash Strain And Project Risk Persist

The bearish view on BICO Group claims that project heavy lab automation, weak operating leverage and cash strain could keep margins fragile for longer. Q2 takes some edge off that story but does not close it. Gross margin at 59% and lower operating expenses show better mix and cost control. Yet operating cash flow was still negative, held back by working capital swings, which keeps the concern about cash conversion alive despite a SEK628m cash reserve.

Bears also worry that Biosero style, consulting intensive projects limit scalability and expose BICO Group to lumpier demand. That risk remains visible. Project based automation is still pressured, North America declined and management openly flagged execution challenges in U.S. projects and is “rightsizing” teams. The quarter weakens the argument that margins are structurally broken, but it clearly misses the milestone of proving that integrated automation can deliver consistent, cash generative growth.

After BICO Group’s negative operating cash flow, volatile share price and profitability challenges, review our independent risk analysis for BICO Group which shows 2 important warning signs to identify any overlooked structural vulnerabilities.

Stay Ahead Of Your Next Move

If the mix of easing losses and cash strain at BICO Group has your attention, register for free with Simply Wall St and add it to your Watchlist so you can track price moves against fair value estimates and wait for a setup that fits your plan. Once you decide to take a position, keep your conviction clear by using the Portfolio Command Center to cut through noise and surface only the updates that matter to your holdings. For a broader view on how other investors are thinking about BICO Group and similar stocks, tap into the Community and compare different theses in one place. By spotting fresh catalysts and emerging risks early, you may be able to stay ahead of the market instead of reacting to it.

Seeking Alternatives Beyond BICO Group?

Fresh stock ideas can move from quiet potential to full breakout before most investors even notice. Scan new momentum while it matters and before prices get away. Act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com